Skip to main content
SpringerLink
Log in

Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

In a cross-over trial 16 elderly psychiatric patients with tardive dyskinesia were treated with thioridazine (median dose, 267.5 mg/day) for three months, followed by haloperidol (5.25 mg/day), haloperidol (5.25 mg/day) + biperiden (6 mg/day), thioridazine (267.5 mg/day), and clozapine (62.5 mg/day, only 7 patients), all for periods of 4 weeks with 4-week drug-free intervals. The tardive dyskinesia syndrome and the parkinsonism were evaluated blind according to a self-constructed rating scale and a modified Webster scale from weekly video-tape recordings. At the end of the treatment periods the hyperkinesia score was lower during haloperidol than during either thioridazine for 3 months (total score, 2.2 vs. 3.2, P<0.05), thioridazine for 4 weeks (total score, 2.2 vs. 4.8, P<0.02), or haloperidol + biperiden (score, 2.2 vs. 6.2, P<0.01). Clozapine had no significant antihyperkinetic effect, but in one patient it exerted a clear antiparkinsonian effect. After withdrawal of the initial thioridazine treatment, the hyperkinesia score was lower than after the subsequent haloperidol treatment (6.5 vs. 9.0, P<0.01), but after the second thioridazine period the hyperkinesia was of the same magnitude as after the preceding haloperidol periods. Biperiden increased the tardive dyskinesia syndrome during treatment, but did not significantly influence the syndrome after withdrawal of the treatment.

It is concluded that (1) haloperidol (a strong antidopaminergic neuroleptic) has a more pronounced antihyperkinetic effect than thioridazine and clozapine (weaker antidopaminergic neuroleptics); (2) haloperidol might have a greater tendency to induce tardive dyskinesia than thioridazine; (3) administration of anticholinergics concomitant with neuroleptic drugs antagonizes the antihyperkinetic effect of haloperidol, but may not influence the intensity of tardive dyskinesia after withdrawal of the treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • American College of Neuropharmacology — Food and Drug Administration Task Force: Neurological syndromes associated with antipsychotic drug use. Arch. Gen. Psychiatry 28, 463–467 (1973)

    Google Scholar 

  • Ayd, F. J., Jr.: Persistent dyskinesia: a neurologic complication of major tranquillers. Med. Sci. 18, 32–40 (1967)

    Google Scholar 

  • Barany, S., Gunne, L.-M.: Studies in tardive dyskinesia and acute dystonia. Presented at the VI World Congress of Psychiatry, Honolulu, Hawaii, August 28 – September 3, 1977

  • Bartholini, G.: Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system. J. Pharm. Pharmacol. 28, 429–433 (1976)

    Google Scholar 

  • Bartholini, G., Haefely, W., Jalfre, M., Keller, H. H., Pletscher, A.: Effects of clozapine on cerebral catecholaminergic neurone systems. Br. J. Pharmacol. 46, 736–740 (1972)

    Google Scholar 

  • Bunney, N. S., Aghajanian, G. K.: The effect of antipsychotic drugs on the firing of dopaminergic neurons: a reappraisal. In: Antipsychotic drugs: pharmacodynamics and pharmacokinetics (G. Sedvall, B. Uvnäs, Y. Zotterman, eds.), pp. 305–318 New York: Pergamon 1976

    Google Scholar 

  • Christensen, A. V., Fjalland, B., Møller Nielsen, I.: On the supersensivity of dopamine receptors, induced by neuroleptics. Psychopharmacology 48, 1–6 (1976)

    Google Scholar 

  • Claveria, L. E., Teychenne, P. F., Calne, D. B., Haskayne, L., Petrie, A., Pallis, C. A., Lodge-Patch, I. C.: Tardive dyskinesia treated with pimozide. J. Neurol. Sci. 24, 393–401 (1975)

    Google Scholar 

  • Crane, G. E.: Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Am. J. Psychiatry 124, 40–48 (1968)

    Google Scholar 

  • Crane, G. E.: Persistent dyskinesia. Br. J. Psychiatry 122, 395–405 (1973)

    Google Scholar 

  • Crane, G. E.: Factors predisposing to drug-induced neurologic effects. In: The phenotiazines and structurally related drugs (I. S. Forrest, C. J. Carr, E. Usdin, eds.), pp. 269–279. New York: Raven 1974

    Google Scholar 

  • Doep, S., Buddeberg, C.: Extrapyramidale Symptome unter Clozapin. Nervenarzt 46, 589–590 (1975)

    Google Scholar 

  • Fog, R., Pakkenberg, H.: Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes. Acta Neurol. Scand. 46, 249–251 (1970)

    Google Scholar 

  • Gardos, G., Cole, J. P., La Brie, R. A.: Drug variables in the etiology of tardive dyskinesia application of discriminant function analysis. Prog. Neuro-Psychopharmacol. 1, 147–154 (1977)

    Google Scholar 

  • Gautier, J., Jus, A., Villeneuve, A., Jus, K., Pires, P., Villeneuve, R.: Influence of the antiparkinsonian drugs on the plasma level of neuroleptics. Biol. Psychiatry 12, 389–399 (1977)

    Google Scholar 

  • Gerlach, J.: Relationship between tardive dyskinesia, L-dopa-induced hyperkinesia and parkinsonism. Psychopharmacology 51, 259–263 (1977)

    Google Scholar 

  • Gerlach, J.: Tardive dyskinesia (thesis). Dan. Med. Bull. (in press, 1978)

  • Gerlach, J., Reisby, N., Randrup, A.: Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia (Berl.) 34, 21–35 (1974)

    Google Scholar 

  • Gerlach, J., Rye, T., Kristjansen, P.: Effect of baclofen on tardive dyskinesia. Psychopharmacology 56, 145–151 (1978)

    Google Scholar 

  • Gerlach, J., Thorsen, K.: The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment. Int. Pharmacopsychiatry 11, 1–7 (1976)

    Google Scholar 

  • Gerlach, J., Thorsen, K., Fog, R.: Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients. Psychopharmacologia (Berl.) 40, 341–350 (1975)

    Google Scholar 

  • Gunne, L.-M., Barany, S.: Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology 50, 237–240 (1976)

    Google Scholar 

  • Hyttel, J.: Changes in dopamine synthesis rate in the supersensitivity phase after treatment with a single dose of neuroleptics. Psychopharmacology 51, 205–207 (1977)

    Google Scholar 

  • Kazamatsuri, H., Chien, C., Cole, J. O.: Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate. Arch. Gen. Psychiatry 27, 100–103 (1972)

    Google Scholar 

  • Klawans, H. L., Rubovits, R.: Effect of cholinergic and anticholinergic agents on tardive dyskinesia. J. Neurol. Neurosurg. Psychiatry 27, 941–947 (1974)

    Google Scholar 

  • Overall, J., Gorham, D.: The brief psychiatric rating scale. Psychol. Rep. 10, 799–812 (1962)

    Google Scholar 

  • Sayers, A., Bürki, H., Ruch, W., Asper, H.: Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia (Berl.) 41, 97–104 (1975)

    Google Scholar 

  • Sayers, A., Bürki, H., Ruch, W., Asper, H.: Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects. Psychopharmacology 51, 15–22 (1976)

    Google Scholar 

  • Sayers, A., Bürki, H., Ruch, W., Asper, H.: Animal models for tardive dyskinesia: effects of thioridazine. Pharmakopsychiatry 10, 201–295 (1977)

    Google Scholar 

  • Simpson, G. M., Varga, E.: Clozapine — a new antipsychotic agent. Curr. Ther. Res. 16, 679–686 (1974)

    Google Scholar 

  • Smith, R. C., Davis, J. M.: Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment. Psychopharmacol. Commun. 1, 285–293 (1975)

    Google Scholar 

  • Stille, G., Lauener, H., Eichenberger, E.: The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e] [1,4]diazepine (clozapine). Farmaco, Ed. prat. 26, 603–625 (1971)

    Google Scholar 

  • Tamminga, C. A., Smith, R. C., Ericksen, S. E., Chang, S., Davis, J. M.: Cholinergic influences in tardive dyskinesia. Am. J. Psychiatry 134, 769–774 (1977)

    Google Scholar 

  • Tarsy, D., Baldessarini, R. J.: Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology 13, 927–940 (1974)

    Google Scholar 

  • Tarsy, D., Baldessarini, R. J.: The tardive dyskinesia syndrome. In: Clinical neuropharmacology, vol. 1, (H. L. Klawans, ed.), pp. 29–61. New York: Raven 1976

    Google Scholar 

  • Tarsy, D., Baldessarini, R. J.: The pathophysiologic basis of tardive dyskinesia. Biol. Psychiatry 12, 431–450 (1977)

    Google Scholar 

  • Turek, I., Kurland, A. A., Hanlon, T. E., Bohm, M.: Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs. Br. J. Psychiatry 121, 605–612 (1972)

    Google Scholar 

  • Webster, D. D.: Critical analysis of the disability in Parkinson's disease. Modern Treatment 5, 257–282 (1968)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. G, Sct. Hans Hospital, Roskilde, Denmark

    J. Gerlach & H. Simmelsgaard

Authors
  1. J. Gerlach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Simmelsgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerlach, J., Simmelsgaard, H. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine. Psychopharmacology 59, 105–112 (1978). https://doi.org/10.1007/BF00427742

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00427742

Key words

Search

Navigation